跳至主要内容
临床试验/NCT07179913
NCT07179913进行中(未招募)4 期

The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoperative Depression:A Prospective Radomized Controlled Trial

The First Hospital of Jilin University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
进行中(未招募)
入组人数
40
试验地点
1
主要终点
Hamilton Depression Scale ≥7

研究概览

简要总结

The aim of this study is to observe the antidepressant effect of low-dose esketamine in obese patients with preoperative depression and seeking bariatric surgery. We speculate that intraoperative infusion and the addition of a small dose of esketamine to the postoperative analgesic pump can help reduce the proportion of patients with depression after surgery, and may further improve postoperative recovery, reduce the use of postoperative opioids, shorten postoperative hospital stay, and improve postoperative quality of life of patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥18 years old and <65 years old
  • •Patients with a BMI greater than 35 kg/m^2
  • •Hamilton Depression score ≥7 points
  • •Planned to undergo elective laparoscopic sleeve gastrectomy

排除标准

  • •ASA ≥ grade IV
  • •Those who have had or are currently suffering from mental disorders other than anxiety and depression, such as schizophrenia, bipolar disorder, organic mental disorders, etc.
  • •Those who are unable to cooperate in completing the scale assessment
  • •Have received ketamine/esketamine treatment, or are allergic to ketamine/esketamine
  • •Clarify ischemic cardiomyopathy or severe liver and kidney dysfunction (Child pugh grade C, CKD stage G5)
  • •People with opioid dependence and those who have been taking various types of painkillers for a long time (more than 3 months)
  • •Participate in other research

研究组 & 干预措施

esketamine

Experimental

干预措施: Esketamine (Drug)

dexmedetomidine

Placebo Comparator

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Hamilton Depression Scale ≥7

时间窗: Seven days after the operation

The proportion of patients with depression (Hamilton Depression score ≥7)

次要结局

  • the proportion of patients with depression(30 days, 3 months, 6 month and 1 year after the operation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhiwen Li

study director

The First Hospital of Jilin University

研究点 (1)

Loading locations...

相似试验